Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel

N Marcus, S Frizinsky, D Hagin, A Ovadia… - Frontiers in …, 2021 - frontiersin.org
In the last few months the world has witnessed a global pandemic due to severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease …

Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: a review

BM Liu, HR Hill - Journal of Interferon & Cytokine Research, 2020 - liebertpub.com
Coronavirus disease 2019 (COVID-19) has spread rapidly and become a pandemic.
Caused by a novel human coronavirus called severe acute respiratory syndrome …

[HTML][HTML] Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor?

F Babaha, N Rezaei - The American journal of the medical …, 2020 - ncbi.nlm.nih.gov
The novel coronavirus disease 19 (COVID-19) is an acute infectious respiratory disorder that
emerged from Wuhan, China in the late 2019. 1, 2 Due to its rapid distribution, the disease …

COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience

AM Shields, SO Burns, S Savic, AG Richter… - Journal of Allergy and …, 2021 - Elsevier
Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …

COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review

E Drzymalla, RF Green, M Knuth, MJ Khoury… - Clinical …, 2022 - Elsevier
A better understanding of COVID-19 in people with primary immunodeficiency (PI), rare
inherited defects in the immune system, is important for protecting this population, especially …

Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency

S Delavari, H Abolhassani, F Abolnezhadian… - Journal of clinical …, 2021 - Springer
Although it is estimated that COVID-19 life-threatening conditions may be diagnosed in less
than 1: 1000 infected individuals below the age of 50, but the real impact of this pandemic …

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

AM Shields, A Anantharachagan… - Clinical and …, 2022 - academic.oup.com
Abstract In March 2020, the United Kingdom Primary Immunodeficiency Network (UKPIN)
established a registry of cases to collate the outcomes of individuals with PID and SID …

Common variable immunodeficiency disorders, T-cell responses to SARS-CoV-2 vaccines, and the risk of chronic COVID-19

R Ameratunga, H Longhurst, R Steele, K Lehnert… - The Journal of Allergy …, 2021 - Elsevier
COVID-19 has had a calamitous effect on the global community. Despite intense study, the
immunologic response to the infection is only partially understood. In addition to older age …

Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience

AM Shields, S Tadros, A Al-Hakim, JM Nell… - Frontiers in …, 2022 - frontiersin.org
Background Individuals with primary and secondary immunodeficiency (PID/SID) were
shown to be at risk of poor outcomes during the early stages of the SARS-CoV-2 pandemic …

[HTML][HTML] COVID-19 outcomes in patients undergoing B cell depletion therapy and those with humoral immunodeficiency states: a scoping review

JM Jones, AJ Faruqi, JK Sullivan… - Pathogens and …, 2021 - ncbi.nlm.nih.gov
Background: The role of humoral immunity has been well established in reducing infection
risk and facilitating viral clearance in patients with COVID-19. However, the relationship …